切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (03) : 259 -264. doi: 10.3877/cma.j.issn.2095-3232.2024.03.002

所属专题: 述评 综述

专家论坛

腹腔镜技术在胰腺癌中的应用
廖艳1, 成伟1,()   
  1. 1. 410005 长沙,湖南师范大学附属第一医院(湖南省人民医院)肝胆胰外科
  • 收稿日期:2024-01-30 出版日期:2024-06-10
  • 通信作者: 成伟
  • 基金资助:
    湖南省卫生健康高层次人才项目; 湖南省研究生科研创新项目(CX20220525); 湖南省提高肝胆胰肠疾病诊治能力项目(湘卫〔2019〕118号); 湖南省教育厅重点项目(21A0026)

Application of laparoscopy in pancreatic cancer

Yan Liao1, Wei Cheng1,()   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Hunan Normal University (People's Hospital of Hunan Province), Changsha 410005, China
  • Received:2024-01-30 Published:2024-06-10
  • Corresponding author: Wei Cheng
引用本文:

廖艳, 成伟. 腹腔镜技术在胰腺癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 259-264.

Yan Liao, Wei Cheng. Application of laparoscopy in pancreatic cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(03): 259-264.

外科手术已逐渐向微创方向发展,腹腔镜技术也在外科手术中逐渐展开。而腹腔镜胰腺手术较其他腹腔镜手术开展相对较晚,原因主要在于胰腺位置深,血供丰富,显露困难等。随着微创技术的不断进步,腹腔镜手术已广泛应用于胰腺疾病的手术治疗中,相比开腹手术,腹腔镜手术具有明显的优势。目前腹腔镜技术在胰腺癌中的应用取得重大进展,其在胰腺癌切除术,胰腺癌的分期与活检和晚期姑息治疗中体现出了腹腔镜技术的微创优势,其安全性及有效性也得到了初步的证实。本综述分别从以下方面对腹腔镜技术在胰腺癌中的应用进行探讨。

Surgery has gradually evolved in the direction of minimally invasive procedure, and laparoscopic technique has also been gradually employed in surgery. Compared with other laparoscopic surgeries, laparoscopic pancreatic procedures are adopted relatively later due to the deep location of the pancreas, abundant blood supply and difficult exposure, etc. With the development of minimally invasive techniques, laparoscopic surgery has been widely applied in the surgical treatment of pancreatic diseases, which has evident advantages compared with open surgery. At present, tremendous progress has been made in the application of laparoscopy in pancreatic cancer, illustrating the minimally invasive advantages of laparoscopy in pancreatic cancer resection, staging and biopsy of pancreatic cancer and late palliative treatment. In addition, the safety and efficacy have also been preliminarily validated. In this article, research progress in the application of laparoscopy in pancreatic cancer was reviewed from the following perspectives.

[1]
夏涛,牟一平. 腹腔镜技术在胰腺肿瘤诊治中的应用及前景[J]. 现代实用医学, 2022, 34(3):284-286.
[2]
Kang CM, Lee WJ. Is laparoscopic pancreaticoduodenectomy feasible for pancreatic ductal adenocarcinoma?[J]. Cancers, 2020, 12(11):3430.
[3]
Inoko K, Ebihara Y, Sakamoto K, et al. Strategic approach to the splenic artery in laparoscopic spleen-preserving distal pancreatectomy[J]. Surg Laparosc Endosc Percutan Tech, 2015, 25(4):e122-125.
[4]
Yan JF, Xu XW, Jin WW, et al. Laparoscopic spleen-preserving distal pancreatectomy for pancreatic neoplasms: a retrospective study[J]. World J Gastroenterol, 2014, 20(38):13966-13972.
[5]
余昌中,田驹,杨荣华, 等. 腹腔镜胰体尾切除术在胰尾癌手术治疗中的应用及对生活质量评分的影响研究[J]. 临床外科杂志, 2019, 27(12):1077-1079.
[6]
Zhang YH, Zhang CW, Hu ZM, et al. Pancreatic cancer: open or minimally invasive surgery?[J]. World J Gastroenterol, 2016, 22(32):7301-7310.
[7]
丁琼,虞武斌,高明, 等. 腹腔镜在胰尾切除保脾手术中的临床应用[J]. 浙江创伤外科, 2016, 21(1):166-167.
[8]
Raoof M, Ituarte PHG, Woo Y, et al. Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection[J]. Br J Surg, 2018, 105(5):578-586.
[9]
Coolsen MM, van Dam RM, van der Wilt AA, et al. Systematic review and meta-analysis of enhanced recovery after pancreatic surgery with particular emphasis on pancreaticoduodenectomies[J]. World J Surg, 2013, 37(8):1909-1918.
[10]
Lassen K, Ljungqvist O, Dejong CH, et al. Pancreaticoduodenectomy: ERAS recommendations[J]. Clin Nutr, 2013, 32(5):870-871.
[11]
Riviere D, Gurusamy KS, Kooby DA, et al. Laparoscopic versus open distal pancreatectomy for pancreatic cancer[J]. Cochrane Database Syst Rev, 2016, 4(4):CD011391.
[12]
Gavriilidis P, Roberts KJ, Sutcliffe RP. Laparoscopic versus open distal pancreatectomy for pancreatic adenocarcinoma: a systematic review and meta-analysis[J]. Acta Chir Belg, 2018, 118(5):278-286.
[13]
Kooby DA, Hawkins WG, Schmidt CM, et al. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?[J]. J Am Coll Surg, 2010, 210(5):779-787.
[14]
Stauffer JA, Coppola A, Mody K, et al. Laparoscopic versus open distal pancreatectomy for pancreatic adenocarcinoma[J]. World J Surg, 2016, 40(6):1477-1484.
[15]
Sulpice L, Farges O, Goutte N, et al. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: time for a randomized controlled trial? results of an all-inclusive national observational study[J]. Ann Surg, 2015, 262(5):868-873.
[16]
成伟,滕雄,曾诗语, 等. 腹腔镜下根治性顺行模块化胰脾切除术在胰体尾恶性肿瘤切除中的应用(附6例报告)[J]. 腹腔镜外科杂志, 2018, 23(9):689-693.
[17]
Croome KP, Farnell MB, Que FG, et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?[J]. Ann Surg, 2014, 260(4):633-638.
[18]
Song KB, Kim SC, Hwang DW, et al. Matched case-control analysis comparing laparoscopic and open pylorus-preserving pancreaticoduodenectomy in patients with periampullary tumors[J]. Ann Surg, 2015, 262(1):146-155.
[19]
Feng Q, Liao W, Xin Z, et al. Laparoscopic pancreaticoduodenectomy Versus conventional open approach for patients with pancreatic duct adenocarcinoma: an up-to-date systematic review and meta-analysis[J]. Front Oncol, 2021, 11: 749140.
[20]
Zhou W, Jin W, Wang D, et al. Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis[J]. Cancer Commun, 2019, 39(1):66.
[21]
Yin Z, Jian Z, Hou B, et al. Surgical and oncological outcomes of laparoscopic versus open pancreaticoduodenectomy in patients with pancreatic duct adenocarcinoma[J]. Pancreas, 2019, 48(7):861-867.
[22]
Jiang YL, Zhang RC, Zhou YC. Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis[J]. BMC Cancer, 2019, 19(1):781.
[23]
王小明. 浅谈腹腔镜胰十二指肠切除术的安全性和适应症的选择[J]. 肝胆外科杂志, 2018, 26(1):7-8.
[24]
Zhang RC, Ma J, Mou YP, et al. Short- and long-term outcomes of laparoscopic organ-sparing resection for pancreatic neuroendocrine neoplasms[J]. World J Surg, 2020, 44(11):3795-3800.
[25]
Machado MA, Surjan RC, Epstein MG, et al. Laparoscopic central pancreatectomy: a review of 51 cases[J]. Surg Laparosc Endosc Percutan Tech, 2013, 23(6):486-490.
[26]
赵树超,夏兆志,高鑫, 等. 腹腔镜胰腺中段切除术5例经验总结并文献复习[J]. 腹腔镜外科杂志, 2023, 28(5):339-343.
[27]
Philip PA, Lacy J, Portales F, et al. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT):a multicentre, open-label phase 2 study[J]. Lancet Gastroenterol Hepatol, 2020, 5(3):285-294.
[28]
Bang JY, Krall K, Jhala N, et al. Comparing needles and methods of endoscopic ultrasound-guided fine-needle biopsy to optimize specimen quality and diagnostic accuracy for patients with pancreatic masses in a randomized trial[J]. Clin Gastroenterol Hepatol, 2021, 19(4):825-835, e7.
[29]
Berry W, Lundy J, Croagh D, et al. Reviewing the utility of EUS FNA to advance precision medicine in pancreatic cancer[J]. Cancers, 2018, 10(2):35.
[30]
Tian G, Ye Z, Zhao Q, et al. Complication incidence of EUS-guided pancreas biopsy: a systematic review and meta-analysis of11 thousand population from 78 cohort studies[J]. Asian J Surg, 2020, 43(11):1049-1055.
[31]
林贤超,黄鹤光,陈燕昌, 等. 腹腔镜探查活检术在局部进展期胰腺癌诊治中应用分析[J]. 中国实用外科杂志, 2020, 40(11):1300-1303.
[32]
Maemura K, Shinchi H, Mataki Y, et al. Assessment of percutaneous laparoscopic ultrasonography-guided core needle biopsy for the advanced diagnosis of unresectable pancreatic cancer[J]. JOP, 2015, 16(1):45-49.
[33]
Maemura K, Shinchi H, Mataki Y, et al. Advanced staging laparoscopy using single-incision approach for unresectable pancreatic cancer[J]. Surg Laparosc Endosc Percutan Tech, 2011, 21(6):e301-305.
[34]
Kwon AH, Inui H, Kamiyama Y. Preoperative laparoscopic examination using surgical manipulation and ultrasonography for pancreatic lesions[J]. Endoscopy, 2002, 34(6):464-468.
[35]
Schnelldorfer T, Gagnon AI, Birkett RT, et al. Staging laparoscopy in pancreatic cancer: a potential role for advanced laparoscopic techniques[J]. J Am Coll Surg, 2014, 218(6):1201-1206.
[36]
Mayo SC, Austin DF, Sheppard BC, et al. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?[J]. J Am Coll Surg, 2009, 208(1):87-95.
[37]
Lin X, Lin R, Lu F, et al. Laparoscopic biopsy and staging for locally advanced pancreatic cancer: experiences of 76 consecutive patients in a single institution[J]. Langenbecks Arch Surg, 2021, 406(7):2315-2323.
[38]
Vollmer CM, Drebin JA, Middleton WD, et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies[J]. Ann Surg, 2002, 235(1):1-7.
[39]
国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J].临床肝胆病杂志, 2022, 38(5):1006-1030
[40]
Crippa S, Cirocchi R, Weiss MJ, et al. A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy[J]. Updates Surg, 2020, 72(1):39-45.
[41]
杨尹默,刘光年. 胰腺癌合并肝脏寡转移:联合切除还是姑息治疗[J]. 中华消化外科杂志, 2021, 20(4):376-380.
[42]
浦宁,刘亮,楼文晖. 远处转移胰腺癌手术切除是否合理——国际胰腺病学协会和日本胰腺学会立场声明解读[J]. 中国实用外科杂志, 2023, 43(9): 981-984.
[43]
Satoi S, Yamamoto T, Yamaki S, et al. Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma[J]. Ann Gastroenterol Surg, 2020, 4(1):6-13.
[44]
Ushida Y, Inoue Y, Oba A, et al. Optimizing indications for conversion surgery based on analysis of 454 consecutive Japanese cases with unresectable pancreatic cancer who received modified FOLFIRINOX or gemcitabine plus nab-paclitaxel: a single-center retrospective study[J]. Ann Surg Oncol, 2022, 29(8):5038-5050.
[45]
Hank T, Klaiber U, Hinz U, et al. Oncological outcome of conversion surgery after preoperative chemotherapy for metastatic pancreatic cancer[J]. Ann Surg, 2023, 277(5):e1089-1098.
[46]
DeWitt JM, Sandrasegaran K, O'Neil B, et al. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer[J]. Gastrointest Endosc, 2019, 89(2):390-398.
[47]
Lee D, Komatsu S, Terashima K, et al. Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results[J]. Radiat Oncol, 2021, 16(1):3.
[48]
朱杰,王海彪,陈佰文, 等. 腹腔镜胰腺癌切除手术中静脉侵犯处理7例经验[J]. 中华普通外科杂志, 2022, 37(1):44-46.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?